banner add

Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

from NYT > Health https://ift.tt/j4Eae0u
via IFTTT

No comments

Some Medicare Patients Can Now Get Free CBD

The Trump administration has authorized a test program to see if the cannabis compound can ease some symptoms and reduce health care costs a...

Theme images by PLAINVIEW. Powered by Blogger.